Mechanism of Action
Maitake beta-glucans have a branched architecture that innate immune cells recognize selectively. After ingestion, these polysaccharides interact with specialized receptors on the surface of first-line defense cells. This recognition triggers an intracellular signaling cascade that shifts the vigilance state of these cells.
The effect observed in clinical research is one of modulation, not brute stimulation. A phase II trial followed 18 participants over 12 weeks. Results showed improved neutrophil function (first-response cells) and monocyte function (immune response coordinators). An earlier trial revealed a non-linear dose-response relationship. Intermediate doses produced effects distinct from those of high doses. This profile is characteristic of a biological response modifier.
Key Benefits
- Moderate
A phase II trial involving 18 participants over 12 weeks showed significant improvement in neutrophil function (p = 0.005) and monocyte function (p = 0.021) after daily oral intake of maitake extract.
- Moderate
A clinical trial demonstrated an association between maitake D-fraction intake and increased NK cell (immune surveillance cell) activity in all examined participants.
- Moderate
A dose escalation trial in 34 participants established a statistically significant association (p < 0.0005) between maitake intake and modulation of multiple immune function parameters.
- Emerging
Preliminary human observations suggested a favorable effect of maitake extract on circulating glucose concentrations. These data, from case series, require confirmation through controlled trials.
- Emerging
Grifola frondosa polysaccharides display documented antioxidant activity in several preclinical models. The extent of this effect in humans is the subject of ongoing research.
Dosage & Forms
Three categories of maitake extracts coexist on the market, each offering a different concentration profile. Oral bioavailability of beta-glucans depends on their molecular weight and degree of branching. Forms standardized for polysaccharide content ensure batch-to-batch consistency.
Dosages studied in human clinical trials vary by protocol. The phase II trial by Wesa et al. (2015) used 3 mg/kg twice daily in liquid form over 12 weeks. The trial by Deng et al. (2009) tested a range from 0.1 to 5 mg/kg twice daily. For a concentrated dry extract, common supplementation dosages range from 250 to 500 mg per day.
In the Singular Formula
Inclusion rationale
Large edible mushroom (Grifola frondosa), nicknamed 'hen of the woods' for its characteristic shape of cascading overlapping caps. A treasure of traditional Japanese mycology, maitake has been consumed for centuries both for its culinary qualities and its properties in the herbal tradition. Its composition stands out for its richness in specific beta-glucans called D-fraction, high-molecular-weight polysaccharides whose branched beta-1,3/1,6 structure interacts with innate immunity receptors. Maitake also contains ergosterols (precursors of vitamin D2), B vitamins and minerals. In the formula, it forms a complementary duo with reishi (also present): where maitake primarily contributes its D-fraction beta-glucans, reishi enriches the spectrum with its triterpenes (ganoderic acids), a family of compounds exclusive to the Ganoderma genus. This complementarity between polysaccharides and triterpenes reflects the approach of contemporary functional mycology. The extract is standardized in polysaccharides to ensure consistent active compound content.
Selected form
Fruiting body extract of maitake (Grifola frondosa), standardised in polysaccharides. Maitake, also known as 'hen of the woods', is an edible mushroom that is cultivated and manually harvested. Extraction is performed with water then purified with ethanol, a process that concentrates polysaccharides, particularly beta-glucans: soluble fibres found in the cell wall of mushrooms. The 8:1 extraction ratio means 8 kg of fresh fruiting body yield 1 kg of extract. Most common extracts on the market offer only simple aqueous extraction, without triterpenes. Quality: vegan, non-GMO, pesticide-free.
Formula dosage
0 to 1.2 g.
Synergies in the formula
Linked Biomarkers
Safety & Precautions
Maitake benefits from centuries of culinary use in Japanese food tradition. In supplementation, available clinical trials report good tolerability at studied doses (up to 5 mg/kg twice daily). No dose-limiting toxicity was observed in the phase I/II trial involving 34 participants.
Reported adverse effects remain minor and infrequent: transient digestive discomfort in some consumers. Intake is not recommended for individuals on medication affecting immune defenses, due to potential interaction. It is also not recommended for pregnant or breastfeeding women, in the absence of specific safety data. Individuals on medication for glucose regulation should consult a healthcare professional before supplementation.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Wesa KM et al. | 2015 | Randomised Controlled Trial | Cancer Immunology, Immunotherapy | View on PubMed |
Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study Phase II trial in 18 participants receiving oral maitake extract (3 mg/kg twice daily for 12 weeks). Significant improvement in neutrophil function (p = 0.005) and monocyte function (p = 0.021). | ||||
| Deng G et al. | 2009 | Randomised Controlled Trial | Journal of Cancer Research and Clinical Oncology | View on PubMed |
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects Dose escalation trial in 34 participants (0.1 to 5 mg/kg twice daily for 3 weeks). Significant association between maitake and immune modulation (p < 0.0005), with a non-linear dose-response profile. | ||||
| Kodama N et al. | 2003 | Randomised Controlled Trial | Journal of Medicinal Food | View on PubMed |
Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients Clinical trial evaluating maitake D-fraction. NK cell activity increased in all examined participants. | ||||
| Cerletti C et al. | 2021 | Systematic Review | Nutrients | View on PubMed |
Edible Mushrooms and Beta-Glucans: Impact on Human Health Review of edible mushroom beta-glucan effects on human health, covering immune modulation and glucose and lipid metabolism. | ||||
| He X et al. | 2017 | Systematic Review | International Journal of Biological Macromolecules | View on PubMed |
Polysaccharides in Grifola frondosa mushroom and their health promoting properties: A review Synthesis of three decades of research on Grifola frondosa polysaccharides, documenting immune modulation, antioxidant activity and influence on glucose metabolism. | ||||
| Ulbricht C et al. | 2009 | Systematic Review | Journal of the Society for Integrative Oncology | View on PubMed |
Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration Systematic review identifying three areas of use (immune support, glucose metabolism, oncology) and highlighting the need for additional controlled trials. | ||||
| Konno S et al. | 2001 | Cohort Study | Diabetic Medicine | View on PubMed |
A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients Case series reporting a possible favorable effect of maitake consumption on blood glucose concentrations in adults with glycemic imbalance. | ||||